Medibank Private Sale Act 2006 - Designated Sale Day Declaration 2014

Overview

The Medibank Private Sale Act 2006 was enacted to facilitate the sale of the Commonwealth's entire shareholding in Medibank Private Limited, providing a clear legislative framework for the divestment process. The Act was introduced to address the need for a structured and legally binding mechanism to ensure the sale of Medibank Private was conducted in a manner that provided regulatory and commercial certainty. The enacting body responsible for this Act is the Parliament of Australia, which sought to provide clarity and definitiveness in the sale of the Commonwealth's stake in Medibank Private. The policy objective of the Act is to establish a designated sale day and allow for the effective transition of Medibank Private to private ownership, ensuring all shares are held by entities other than the Commonwealth or its wholly-owned companies.

Scope and Application

The Medibank Private Sale Act 2006 is an Australian Commonwealth Act that pertains specifically to the sale of shares in Medibank Private Limited by the Commonwealth. This Act applies to the Commonwealth, wholly-owned Commonwealth companies, and the shares of Medibank Private Limited, with the primary aim of formalising the sale of these shares to private entities. The Act ensures that the sale of these shares is conducted in a manner that provides regulatory and commercial certainty. The geographic reach of this Act is limited to the Commonwealth level, meaning it applies nationally within Australia. The Act excludes any shares held by the Commonwealth or its wholly-owned entities post the designated sale day, which is declared by the Minister for Finance. This Act is complemented by subordinate instruments that provide further details on the legislative process, including registration and tabling requirements, without being subject to Parliamentary disallowance. The Explanatory Statement specifies that the sale was completed on 1 December 2014, marking the designated sale day when all shares were divested from the Commonwealth and wholly-owned Commonwealth companies.

Key Provisions

The Medibank Private Sale Act 2006, and in particular the accompanying Designated Sale Day Declaration 2014, establish the framework for the sale of shares in Medibank Private Limited, formerly held by the Commonwealth. Section 3(1) of the Act sets out the criteria for the designated sale day, which is determined by the Minister for Finance and declared through a written instrument. The Act stipulates that the designated sale day is the first day after the commencement of Schedules 1 and 2, during which all shares in Medibank Private are held by entities other than the Commonwealth or a wholly-owned Commonwealth company. This requirement ensures regulatory and commercial certainty by clearly defining the moment when the sale is considered complete from a legislative perspective. The obligations under the Act are primarily centered around the declaration process and the timing of the sale. Section 3(3) of the Act requires the instrument declaring the designated sale day to be registered on the Federal Register of Legislative Instruments and tabled in both Houses of Parliament, but exempts it from Parliamentary disallowance under section 42 of the Legislative Instruments Act 2003. This means that while the instrument must be made public and officially recorded, it does not need to be subject to the potential veto by Parliament. The Minister for Finance, having consulted with the Department of Finance, declared 1 December 2014 as the designated sale day based on the completion of the Medibank Private Share Offer and the absence of any Commonwealth or wholly-owned Commonwealth company shares in Medibank Private as of that date. Offences and penalties under the Medibank Private Sale Act 2006 are not explicitly detailed in the provided text. However, the seriousness of the legislative instrument implies that adherence to the declared sale day and the procedural requirements outlined in the Act are crucial. Breaches of these obligations, if they existed, might entail administrative or legal consequences, although the specific penalties are not outlined in the text. The focus of the Act appears to be more on providing clarity and ensuring a smooth transition of ownership rather than penalising non-compliance. The Medibank Private Sale Act 2006, as supplemented by the Designated Sale Day Declaration 2014, ensures that the sale of Medibank Private shares is executed in a legally defined and transparent manner. This legislative approach provides both regulatory certainty and a clear timeline for the transfer of ownership, facilitating the privatisation process while adhering to necessary formalities.